Nahdi Medical Company
4164.SRSAUHealthcare● Active
$95.40
$-0.10(-0.10%)
Market Cap$12.4B
P/E Ratio—
52W High$132.1
52W Low$91
Nahdi Medical Company（4164.SR）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · 4164.SR · 截至 2026-06-15
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $10.21B | $9.45B | $8.71B | $8.62B | $8.07B |
| Cost of Revenue | $6.41B | $5.91B | $5.28B | $5.10B | $4.76B |
| Gross Profit | $3.81B | $3.53B | $3.44B | $3.52B | $3.30B |
| Gross Margin %(computed) | 37.26% | 37.40% | 39.43% | 40.86% | 40.97% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.06B | $0.06B | $0.08B | $0.07B | $0.05B |
| Total Operating Expenses | $2.88B | $2.66B | $2.47B | $2.53B | $2.43B |
| Operating Income | $0.91B | $0.87B | $0.96B | $1.00B | $0.92B |
| Operating Margin %(computed) | 8.89% | 9.24% | 11.03% | 11.64% | 11.40% |
| Interest Income | $0.05B | $0.05B | $0.06B | $0.01B | $0.00B |
| Interest Expense | $0.14B | $0.12B | $0.08B | $0.08B | $0.08B |
| Income Before Tax | $0.85B | $0.83B | $0.94B | $0.94B | $0.86B |
| Income Tax Expense | $0.02B | $0.01B | $0.05B | $0.05B | $0.04B |
| Net Income | $0.83B | $0.82B | $0.89B | $0.89B | $0.81B |
| Net Margin %(computed) | 8.13% | 8.69% | 10.24% | 10.30% | 10.07% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $6.39 | $6.31 | $6.87 | $6.83 | $6.25 |
| Wtd Avg Shares | 0.13B | 0.13B | 0.13B | 0.13B | 0.13B |
| EBITDA | $1.69B | $1.61B | $1.64B | $1.59B | $1.51B |
| EBITDA Margin %(computed) | 16.54% | 17.06% | 18.86% | 18.40% | 18.68% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-15 · SAR · B
深入了解Nahdi Medical Company
关于Nahdi Medical Company（4164.SR）损益表
Nahdi Medical Company（4164.SR）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，4164.SR实现营收$10.21B，毛利润$3.81B（毛利率37.26%），净利润$0.83B（净利率8.13%）。
常见问题
4164.SR · 4 问Nahdi Medical Company（4164.SR）2025财年营收为$10.21B，同比up8.1%。
4164.SR revenue4164.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15